Human Primary Mast Cells

Evaluate in vitro mast cell response

Human primary mast cells for research

Reliable human data on drug efficacy & toxicity

Today’s research on new drugs is often complicated by a consistent lack of relevant study tools. This is also the case when it comes to research on mast cells, where rodent and human cell line models are still the standard and human primary mast cells remain notoriously hard to obtain. Genoskin provides a reliable solution to help you study human primary mast cell response to your compound or formula. You’ll find a quick overview of our offer below.

Safety assessment

Monitor mast cell degranulation to evaluate potential drug toxicity and identify adverse effects mediated by mast cells.

Allergic risk reactions

Analyze a drug candidate effects on mast cells degranulation to help assess its potential for inducing allergic responses in patients.

Drug efficacy

Evaluate a drug’s ability to trigger mast cell
degranulation as a marker of immune activation
or inhibit/deplete mast cells.

Ready to test in vitro-derived mast cells in your lab?

Unlock new research potential with our reliable human primary mast cells—now available for your experiments!

Genoskin is excited to offer Human Peripheral Blood-derived Mast Cells (PBCMCs) as a product, empowering you to conduct cutting-edge research directly in your own lab. These mast cells, which are cultured from peripheral blood CD34+ progenitor cells, are, integral to immune responses, are essential for research on allergic reactions, immune system responses, and a range of pathologies. Genoskin’s functional human primary mast cells are designed for in vitro research on drug efficacy, toxicity, and immune responses, with reliable degranulation in response to anti-IgE stimulation.

Ready to enhance your research? Our mast cells are waiting for you. Now, you can take full control of your experiments with these powerful cells, all at your fingertips—ready to be used in your lab at your convenience.

request a quote

Human primary mast cells

Key players in immunology

Mast cells play an important role in how the immune system responds to certain bacteria and parasites and they also help control other types of immune responses. They have been mostly viewed as effectors of allergy and it has only been in the last two decades that they have gained significant attention for their involvement in a range of other physiological and pathological processes. Mast cells are a type of white blood cell found in connective tissues throughout the human body. Investigations have shown that they are present in the skin and in nearly all vascularized organs, including heart, lungs, kidneys, intestine, liver and in the brain side of the blood-brain barrier. They contain chemicals such as histamine, heparin, cytokines, and growth factors, which they release during allergic reactions and certain immune responses (Sarit Pal et al., 2020).

First-in-human data on drug efficacy and toxicity

A unique platform to de-risk drug development

As human primary mast cells are notoriously hard to obtain for research purposes, Genoskin has developed a unique process using peripheral blood samples from healthy adult donors. This 1-month process yields mature mast cells that show the same metabolism and expression as the mast cells in the human body, with the phenotype of connective tissue-type mast cells:

The granules are filed with heparin, tryptase and chymase
They express the high affinity receptor for IgE (FcεR1α), MRGPRX2 (specifically expressed by skin mast cells), FcgRs and many G protein-coupled receptors including receptors for complement anaphylatoxins
They can degranulate and produce cytokines/chemokines in response to many stimuli including IgE/anti-IgE, cationic molecules that bind to MRGPRX2 (e.g neuropeptide substance P and FDA-approved drugs), C3a and C5a, endothelin-1,…

First-in-human data on drug efficacy and toxicity: A unique platform to de-risk drug development

The cells exhibit a mature mast cell profile, with the characteristic size and granularity of fully differentiated mast cells. Expression of the key receptors CD117, FcεRI, C3aR, and MRGPRX2 has also been confirmed, enabling the study of both IgE-dependent and IgE-independent activation pathways.

Induction of degranulation with reference compounds

Measure of β-hexosaminidase activity in culture supernatant upon stimulation with reference compounds.

Conditions of experimentation:

Stimulation at day 1
3 replicates for a single donor

**** p-values from T-tests performed between water and indicated compounds (<0.0001= extremely significant)

Induction of degranulation with reference compounds

CD63 Staining via Flow Cytometry: A Powerful Tool for Mast Cell Degranulation Studies

Genoskin expands its non-clinical testing services with the introduction of CD63 staining via flow cytometry. This advanced method enhances the measurement of mast cell degranulation studies by precisely measuring CD63 surface expression at the single-cell level. Ideal for drug development, safety assessments, and immune research, CD63 staining allows for high-sensitivity detection of degranulation and can be paired with other markers for multi-parameter analysis.

Substance P activation

Anti-IgE activation

Need more information?

Don’t hesitate to contact us for more information.

Resources

September 2016 - Different activation signals induce distinct mast cell degranulation strategies

Different activation signals induce distinct mast cell degranulation strategies
- Published in The Journal of Clinical Investigation – September 19, 2016
  - Nicolas Gaudenzio, Riccardo Sibilano, Thomas Marichal, Philipp Starkl, Laurent L. Reber, Nicolas Cenac, Benjamin D. McNeil, Xinzhong Dong, Joseph D. Hernandez, Ronit Sagi-Eisenberg, Ilan Hammel, Axel Roers, Salvatore Valitutti, Mindy Tsai, Eric Espinosa, and Stephen J. Galli.

March 2013 - Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype

Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype
- Published in The Journal of Allergy and Clinical Immunology – March 20,2013
  - Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti, MD, Eric Espinosa, PhD

Mast cells factsheet

Enhance your drug development with human primary mast cells.

Download the factsheet

Webinar – Mast Cells: Can’t live with them, can’t live without them?

April 8, 2024 – Prof. Marcus Maurer

In this webinar, Prof. Maurer focuses on the dual role of mast cells in health and inflammatory diseases.

Access here

Webinar – MRGPRX2+ Mast Cells : From Biology to Clinical Perspective in Skin Immunology

In this webinar, Dr. Gaudenzio discusses how skin mast cells integrate different stimuli to regulate their activation program and the consequences on frequent dermatoses. And more!